Business Standard

Laurus Labs hits 4-month low; stock slips 14% in 3 days post mixed Q2FY23

Despite mixed Q2FY23 performance, brokerages retain their 'buy' rating on Laurus Labs with a target price in the range of Rs 610 and Rs 630 per share.

Laurus Labs
Premium

Laurus Labs

SI Reporter Mumbai
Shares of Laurus Labs declined 6 per cent to hit four-month low of Rs 450 apiece in Tuesday’s intra-day trade, on the back of heavy volumes. The stock traded at its lowest level since June 23, 2022.

At 02:15 PM; the stock quoted 5 per cent lower at Rs 456.75, as compared to 0.19 per cent decline in the S&P BSE Sensex. The trading volumes on the counter jumped nearly five-fold as around 6.5 million shares exchanged hands on the NSE and BSE.

In the past three days, the stock of pharmaceuticals company slipped 14 per cent and reported

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 25 2022 | 2:48 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com